Leading CROs and CDMOs turn to mass photometry for rapid protein, mRNA and viral vector analytics
Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies
Refeyn Ltd recognized as a Top Employer for 2026 in the UK
Mass photometry (MP) and macro mass photometry (MMP): A side-by-side comparison for drug development
Mass Photometry: 103 Understanding low-affinity interactions with MassFluidix™ HC
Revealing retroviral integration complex assembly with mass photometry and MassFluidix™ HC
Enhancing cryo-EM workflows with mass photometry: A smarter pre-screening approach
Refeyn Announces Leadership Transition: Jonathan Flint Steps Down as Chairman, Jean-Paul Mangeolle Appointed as Successor
How does mass photometry work? 2025
New milestone: 500 mass photometers installed globally